Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.

Drug News

Joan David-Leonhard

BridGene Biosciences and Galapagos NV Join Forces in Landmark Collaboration for Oncology Drug Discovery

BridGene Biosciences, Inc., a trailblazer in small molecule drug discovery for challenging targets, has announced a strategic collaboration and licensing…
Read More »
Drug News

Joan David-Leonhard

AbelZeta Pharma, Inc. Establishes Scientific Advisory Board to Propel Advancements in Inflammatory and Immunological Diseases

AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company specializing in the discovery and development of innovative cell-based therapeutic products, has…
Read More »
Drug News

Joan David-Leonhard

Hi-Tech Pharmaceuticals Expands Production Capabilities to Revolutionize Dietary Supplements and OTC Drugs

Hi-Tech Pharmaceuticals, Inc., a leading global healthcare supplier, has announced a significant expansion in its manufacturing capabilities for dietary supplements…
Read More »
Drug News

Joan David-Leonhard

Novartis Secures Groundbreaking $100 Million Deal with Voyager for Cutting-Edge Gene Therapy Partnership

On January 2, Voyager Therapeutics announced a significant licensing deal with Swiss-based drugmaker Novartis, wherein Novartis would make an upfront…
Read More »
Drug News

Joan David-Leonhard

Glenmark Makes History: Unveils India’s First Biosimilar of Liraglutide, a Game-Changer in Diabetes Treatment

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular10,11 anti-diabetic drug, Liraglutide, for the…
Read More »
Drug News

Joan David-Leonhard

MediLink’s Global Pact with Roche Unveils Revolutionary Oncology Breakthrough

MediLink Therapeutics has recently unveiled a groundbreaking collaboration and license agreement with Roche, a leading pharmaceutical company, for the development…
Read More »
Drug News

Joan David-Leonhard

US FDA Approvals Bounce Back In 2023, Sparking Hopes of a Biotech Recovery

The surge in U.S. Food and Drug Administration (FDA) approvals in 2023 has ignited optimism within the biotech industry, signaling…
Read More »
Medicines

Joan David-Leonhard

Top 10 Active Pharmaceutical Ingredients (APIs) and Leading Companies In The Sector

Active Pharmaceutical Ingredients (APIs) serve as the essential bioactive components in pharmaceutical drugs, whether synthesized chemically, produced through biotechnological methods,…
Read More »
Drug News

Joan David-Leonhard

Ascentage Pharma Takes Center Stage: CEO Dr. Dajun Yang to Unveil Innovations at 42nd J.P. Morgan Healthcare Conference

Ascentage Pharma, a global biopharmaceutical company specializing in novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, has…
Read More »
Drug News

Joan David-Leonhard

Dollar Landscape of Biological Drug API Manufacturing Services – A Decade of Growth and Collaboration (2023-2033)

The Biological Drug API Manufacturing Services Market Report for 2023-2033, presented by Research and Markets, underscores key developments in the…
Read More »

Previous page Next page

Adblock Detected